Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04866303 · ClinicalTrials.gov registry record · NA
Protecting Our Community: COVID-19 Testing
A NA study, sponsored by Montana State University.
- Completed
- Registry status
- NA
- Development phase
- 273
- Enrollment target
NCT04866303 is a NA study that has completed, run by Montana State University. The registered enrollment target is 273 participants.
The verdict
NCT04866303, a NA study, has completed, sponsored by Montana State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 273 participants
- Enrollment target
Study Summary
The COVID-19 pandemic has disproportionately affected American Indian (AI) and Latino communities, and these groups also have increased risk of poor prognosis due to high rates of chronic disease such as diabetes, cardiovascular disease, and cancer. In the northwestern United States, AI and Latino communities already face significant disparities in health care access, which have been further exacerbated by the COVID-19 pandemic. In the proposed study, Protecting Our Community: A Pragmatic Randomized Trial of Home-Based COVID Testing with Native American and Latino Communities, the investigators will leverage our long-term community-based participatory research partnerships to test the hypothesis that home-based testing will be feasible, impactful, and better-accepted using active delivery of test kits by trusted community health educators in two vulnerable, high-risk rural communities. Our two long-term partner communities are the Flathead Indian Reservation of the Confederated Salish and Kootenai Tribes in Montana, and the Yakima Valley of Washington, a large Latino community. The investigators will determine the cultural, social, behavioral, and economic barriers to home-based SARS-CoV-2 testing; culturally adapt and enhance home-testing educational materials and create home-testing instructional graphics and YouTube videos; conduct a 2-arm pragmatic randomized trial of active (delivered by community health educator) vs. passive (without community health educator) home-based testing kits (n = 200/community) for testing completion; and create a model for community-driven testing protocols that can have significant impact for increasing home-based testing uptake among AI and Latino communities nationally. This work will enable underserved AI and Latino communities to take full advantage of the coming wave of rapid point-of-care home tests and decrease the significant impact of COVID-19 in their communities.
Interventions
- DIAGNOSTIC_TEST Home-based SARS-CoV-2 test kit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2021-04-26 |
| Est. Completion | 2022-03-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04866303
The ClinicalTrials.gov registry entry for NCT04866303 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montana State University, which has 36 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Home-based SARS-CoV-2 test kit is the first listed.
NCT04866303 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04866303 about?
NCT04866303 is a clinical study titled "Protecting Our Community: COVID-19 Testing". The COVID-19 pandemic has disproportionately affected American Indian (AI) and Latino communities, and these groups also have increased risk of poor prognosis due to high rates of chronic disease such as diabetes, cardiovascular disease, and cancer. In the northwestern United States, AI and Latino c...
What is the current status of trial NCT04866303?
This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 2021-04-26. Estimated completion is 2022-03-09.
What interventions are being tested in trial NCT04866303?
The interventions under investigation include: Home-based SARS-CoV-2 test kit (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04866303?
This trial is sponsored by Montana State University, which has 36 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.